Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA issues warning letter to Divis Labs for Vizag unit

      USFDA issues warning letter to Divis Labs for Vizag unit

      Ruby Khatun Khatun24 April 2017 12:04 PM IST
      NEW DELHI: Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Visakhapatnam...
      Dr Reddy

      Dr Reddy's launches generic Progesterone capsules in US

      Ruby Khatun Khatun24 April 2017 12:02 PM IST
      New Delhi: Drug firm Dr Reddy's today said it has launched generic Progesterone capsules used in treatment of menstrual irregularities and protection...
      USFDA issues 11 observations for Sun Pharma

      USFDA issues 11 observations for Sun Pharma's Dadra facility

      Ruby Khatun Khatun24 April 2017 12:00 PM IST
      A Form-483 observation letter was issued by the USFDA post the inspection, listing 11 observations.New Delhi: Drug major Sun Pharmaceutical Industries...
      Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

      Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

      Ruby Khatun Khatun23 April 2017 1:38 PM IST
      Patna: Bihar Drug Controller and Bihar police recently raided the godowns of a drug company and seized fake and expired medicines worth over Rs 10...
      Combiflam, Oflox 100 and D Cold Total substandard : CDSCO

      Combiflam, Oflox 100 and D Cold Total substandard : CDSCO

      Ruby Khatun Khatun23 April 2017 12:58 PM IST
      New Delhi: The Central Drugs Standard Control Organization (CDSCO) has found popular medicines like Combiflam, a painkiller and D Cold Total tablets...
      Unfortunate: Biotech firm pulls pioneering gene therapy due to no demand

      Unfortunate: Biotech firm pulls pioneering gene therapy due to no demand

      Ruby Khatun Khatun23 April 2017 10:17 AM IST
      By Ben HirschlerLONDON: The biotech company behind the Western world's first gene therapy and the most expensive prescription medicine in history is...
      Narayana Hrudayalaya inks pact with Panacea Biotec

      Narayana Hrudayalaya inks pact with Panacea Biotec

      Ruby Khatun Khatun22 April 2017 12:57 PM IST
      The company has“entered into a definitive agreement to acquire 100 per cent stake in NewRise Healthcare Pvt Ltd from Panacea Biotec Ltd to announce...
      EMA panel recommends nod for Sanofi, Regenerons arthritis drug

      EMA panel recommends nod for Sanofi, Regeneron's arthritis drug

      Ruby Khatun Khatun22 April 2017 12:47 PM IST
      A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat...
      Valeant prices psoriasis treatment at $3,500 per month

      Valeant prices psoriasis treatment at $3,500 per month

      Ruby Khatun Khatun22 April 2017 12:21 PM IST
      Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month,...
      FDA approves Samsung Bioepis copy of J&Js Remicade: company

      FDA approves Samsung Bioepis' copy of J&J's Remicade: company

      Ruby Khatun Khatun22 April 2017 12:20 PM IST
      South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson's rheumatoid...
      US drug Regulator links Sanofi epilepsy drug to child deformities

      US drug Regulator links Sanofi epilepsy drug to child deformities

      Ruby Khatun Khatun22 April 2017 10:06 AM IST
      By Matthias BlamontPARIS: Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against...
      GSK to pay $3 million to wife of lawyer who committed suicide after taking generic version of Paxil: US Court

      GSK to pay $3 million to wife of lawyer who committed suicide after taking generic version of Paxil: US Court

      Ruby Khatun Khatun21 April 2017 10:42 AM IST
      By Nate Raymond and Barbara GrzincicChicago : GlaxoSmithKline(GSK.L) must pay $3 million to a woman who sued the drug company over the death of her...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok